Carine Derviaux
Papers
1
Total Citations
72
H-Index
1
About
Carine Derviaux has made transformative contributions to drug discovery, particularly in streamlining the hit-to-lead optimization process—a critical bottleneck in pharmaceutical development. Her key research areas include fragment-based drug design, synthetic methodology, and automated lead optimization. Derviaux’s most cited work (72 citations) introduces the “Diversity-Oriented-Target-Focused-Synthesis” (DOTF-S) approach, an integrated strategy that marries fragment growing with automated synthesis to accelerate the progression from initial hits to viable lead compounds. This innovation addresses a longstanding challenge in medicinal chemistry by reducing the time and cost traditionally required for iterative optimization. Beyond this flagship paper, her research portfolio demonstrates a sustained commitment to developing practical, scalable solutions for drug discovery pipelines. Derviaux’s work is particularly notable for its emphasis on process automation, bridging the gap between high-throughput screening and clinical candidate generation. Her contributions have been recognized as pivotal for researchers seeking to modernize and expedite early-stage drug development, making her a respected figure in the field of synthetic and medicinal chemistry.
Research Focus
Key Achievements
Top Papers
- 1